Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
clinical trials
life sciences
national blog main
brexit
drugs
europe
europe blog main
falsified medicines
innovation
labeling
mhra
regulations
uk
fda
national
avapritinib
bempedoic acid
blueprint medicines
boston
boston blog main
boston top stories
cholesterol
corticosteroids
cstone pharmaceuticals
deals
detroit
detroit blog main
detroit top stories
eli lilly
esperion therapeutics
european medicines agency
ezetimibe
fisogatinib
flatiron health
fluoroquinolones
genentech
hepatocellular carcinoma
investing
jeff albers
What
medicines
5
×
regulatory
5
×
brexit
charting
choppy
course
dynamic
end
period
plans
post
regulation
reveals
transition
uk
drug
fda
wins
approval
approved
blueprint
cancer
candidate
cholesterol
combo
currently
esperion
esperion’s
levels
lowering
marketing
muscle
nod
pact
pairs
pill
ret
review
roche
second
Language
unset
Current search:
regulatory
×
medicines
×
biotech
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System